Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial (Q56945043)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1998

Language	Label	Description	Also known as
English	Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) Trial	scientific article published on 01 December 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

platelet aggregation

1 reference

based on heuristic

inferred from title

0 references

language of work or name

0 references

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

2003-2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelets and thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjunctive Antiplatelet Therapy in Acute Myocardial Infarction: The Road to Improved Infarct-Related Artery Patency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

EPILOG and CAPTURE trials halted because of positive interim results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina. The Canadian Lamifiban Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Heuristic and logistic principles of ST-segment interpretation in the time domain. Evolution in the context of the TAMI 7 trial design

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events i

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900474-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(98)00474-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9857885%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56945043&oldid=1946509841"